Drug Ineffective has been reported as an adverse reaction across 25 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 98,545 adverse event reports mention drug ineffective in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with drug ineffective, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
Haleon Us Holdings Llc Drugs Reporting Drug Ineffective
The following Haleon Us Holdings Llc drugs have drug ineffective listed in their FDA adverse event reports, sorted by report count:
Which Haleon Us Holdings Llc drugs cause Drug Ineffective?
25 drug(s) manufactured by Haleon Us Holdings Llc have drug ineffective listed in their FDA adverse event reports: DICLOFENAC SODIUM, FLUTICASONE PROPIONATE, DOCOSANOL, IBUPROFEN SODIUM, GLYCERIN, LIDOCAINE, and others.
How many Drug Ineffective reports are there for Haleon Us Holdings Llc drugs?
There are a combined 98,545 reports of drug ineffective across 25 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.